FDA Warning Letters Released The Weeks Of Feb. 24 And March 10
This article was originally published in The Gray Sheet
FDA hits U.S. device firm and research institute with warning letters.
You may also be interested in...
While good clinical practice inspectors in the UK and the US collaborate on matters of common interest, they say that mutual recognition is simply not possible.
Last year, Mallinckrodt attempted restructuring the firm to evade bankruptcy fears. However, the company is now filing for bankruptcy for its US generics business to address “unmanageable liabilities.”
Informa Pharma Intelligence has officially launched the seventh Global Generics & Biosimilars Awards, which will take place in October 2020 in Milan, Italy.